Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

Open access

Abstract

BACKGROUND: Risedronate increases bone mineral density in elderly women, but whether it prevents hip fracture is not known. METHODS: We studied 5445 women 70 to 79 years old who had osteoporosis (indicated by a T score for bone mineral density at the femoral neck that was more than 4 SD below the mean peak value in young adults [-4] or lower than -3 plus a nonskeletal risk factor for hip fracture, such as poor gait or a propensity to fall) and 3886 women at least 80 years old who had at least one nonskeletal risk factor for hip fracture or low bone mineral density at the femoral neck (T score, lower than -4 or lower than -3 plus a hip-axis length of 11.1 cm or greater). The women were randomly assigned to receive treatment with oral risedronate (2.5 or 5.0 mg daily) or placebo for three years. The primary end point was the occurrence of hip fracture. RESULTS: Overall, the incidence of hip fracture among all the women assigned to risedronate was 2.8 percent, as compared with 3.9 percent among those assigned to placebo (relative risk, 0.7; 95 percent confidence interval, 0.6 to 0.9; P=0.02). In the group of women with osteoporosis (those 70 to 79 years old), the incidence of hip fracture among those assigned to risedronate was 1.9 percent, as compared with 3.2 percent among those assigned to placebo (relative risk, 0.6; 95 percent confidence interval, 0.4 to 0.9; P=0.009). In the group of women selected primarily on the basis of nonskeletal risk factors (those at least 80 years of age), the incidence of hip fracture was 4.2 percent among those assigned to risedronate and 5.1 percent among those assigned to placebo (P=0.35). CONCLUSIONS: Risedronate significantly reduces the risk of hip fracture among elderly women with confirmed osteoporosis but not among elderly women selected primarily on the basis of risk factors other than low bone mineral density.

Overview

Integrity signals

Registry

Crossref · 10.1056/nejm200102013440503

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 25 references

Cited by

See all 1,918

Metadata

Authors
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., Meunier, P. J., Wasnich, R. D., Greenwald, M., Kaufman, J.-M., Chesnut, C. H., & Reginster, J.-Y.
Affiliations
  • Providence Portland Medical Center (US)
  • Maastricht University (NL)
  • Colorado Center for Bone Research (US)
  • Humboldt-Universität zu Berlin (DE)
  • McMaster University (CA)
  • Hôpital Cochin (FR)
  • Guy's Hospital (GB)
  • St George Hospital (AU)
  • University of Sheffield (GB)
  • Hôpital Edouard Herriot (FR)
  • Ghent University Hospital (BE)
  • University of Washington (US)
  • University of Liège (BE)
Venue
New England Journal of Medicine
Published
2001-02
Volume
344
Issue
5
Pages
333-340
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2102123887
Cited by
1,918
References
25
Citations by year
2026: 8 · 2025: 21 · 2024: 28 · 2023: 33 · 2022: 43 · 2021: 30 · 2020: 42 · 2019: 29 · 2018: 44 · 2017: 51 · 2016: 54 · 2015: 62 · 2014: 69 · 2013: 82 · 2012: 68
FWCI
123.29
Type
journal article
Language
en
Open access
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Document Server@UHasselt (UHasselt) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion)
  • ORBi (University of Liège) (submittedVersion)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Surgery › Hip and Femur Fractures
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
Keywords
risedronate, hip fracture, osteoporosis, older women, bisphosphonates, bone mineral density, femoral neck, fracture prevention, fall risk, osteopenia
MeSH terms
Risedronic Acid, Aged, Aged, 80 and over, Calcium Channel Blockers, Female, Hip Fractures, Humans, Risk Factors, Etidronic Acid, Bone Density, Osteoporosis, Postmenopausal, Incidence, Fractures, Bone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Risedronate on the Risk of Hip Fracture in Elderly Women. https://app.cochat.ai/papers/10.1056/nejm200102013440503
The paper
McClung, M. R., Geusens, P., Miller, P. D., Zippel, H., Bensen, W. G., Roux, C., Adami, S., Fogelman, I., Diamond, T., Eastell, R., Meunier, P. J., Wasnich, R. D., Greenwald, M., Kaufman, J.-M., Chesnut, C. H., & Reginster, J.-Y. (2001). Effect of Risedronate on the Risk of Hip Fracture in Elderly Women. New England Journal of Medicine. https://doi.org/10.1056/nejm200102013440503

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.